Menu
Back to Journals » ImmunoTargets and Therapy » Volume 9 » default
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (171)
- Volume 13, 2024 (16)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 9, 2020
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity
van Gool MMJ, van Egmond M
ImmunoTargets and Therapy 2020, 9:351-372
Published Date: 5 January 2021
Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery
Horkowitz AP, Schwartz AV, Alvarez CA, Herrera EB, Thoman ML, Chatfield DA, Osborn KG, Feuer R, George UZ, Phillips JA
ImmunoTargets and Therapy 2020, 9:333-350
Published Date: 17 December 2020
Complement Inhibition for the Treatment of Myasthenia Gravis
Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P
ImmunoTargets and Therapy 2020, 9:317-331
Published Date: 15 December 2020
Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications
Lillo AM, Velappan N, Kelliher JM, Watts AJ, Merriman SP, Vuyisich G, Lilley LM, Coombs KE, Mastren T, Teshima M, Stein BW, Wagner GL, Iyer S, Bradbury ARM, Harris JF, Dichosa AE, Kozimor SA
ImmunoTargets and Therapy 2020, 9:299-316
Published Date: 27 November 2020
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
Jefremow A, Neurath MF
ImmunoTargets and Therapy 2020, 9:289-297
Published Date: 26 November 2020
Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma
Sepe P, Mennitto A, Corti F, Procopio G
ImmunoTargets and Therapy 2020, 9:273-288
Published Date: 13 November 2020
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR
ImmunoTargets and Therapy 2020, 9:255-272
Published Date: 10 November 2020
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases
Tanaka Y, Hoshino-Negishi K, Kuboi Y, Tago F, Yasuda N, Imai T
ImmunoTargets and Therapy 2020, 9:241-253
Published Date: 4 November 2020
GM-CSF: A Promising Target in Inflammation and Autoimmunity
Lee KMC, Achuthan AA, Hamilton JA
ImmunoTargets and Therapy 2020, 9:225-240
Published Date: 29 October 2020
The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria
Toubi E, Vadasz Z
ImmunoTargets and Therapy 2020, 9:217-223
Published Date: 22 October 2020
Immunotherapeutic and Targeted Approaches in Multiple Myeloma
Nadeem O, Tai YT, Anderson KC
ImmunoTargets and Therapy 2020, 9:201-215
Published Date: 14 October 2020
Therapeutic Vaccines for HPV-Associated Malignancies
Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C
ImmunoTargets and Therapy 2020, 9:167-200
Published Date: 7 October 2020
Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?
Li J, Bao G, Wang H
ImmunoTargets and Therapy 2020, 9:157-166
Published Date: 5 October 2020
Targeting IL-4 for the Treatment of Atopic Dermatitis
Chiricozzi A, Maurelli M, Peris K, Girolomoni G
ImmunoTargets and Therapy 2020, 9:151-156
Published Date: 29 September 2020
Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine
Andualem H, Kiros M, Getu S, Hailemichael W
ImmunoTargets and Therapy 2020, 9:143-149
Published Date: 29 September 2020
Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum]
Ganjali R, Ghorban Sabbagh M, Nazemiyan F, Mamdouhi F, Badiee Aval S, Taherzadeh Z, Heshmati Nabavi F, Golmakani R, Tohidinezhad F, Eslami S
ImmunoTargets and Therapy 2020, 9:141-142
Published Date: 14 September 2020
Cannabidiol as a Novel Therapeutic for Immune Modulation
Peyravian N, Deo S, Daunert S, Jimenez JJ
ImmunoTargets and Therapy 2020, 9:131-140
Published Date: 18 August 2020
Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model
Papaevangelou E, Smolarek D, Smith RA, Dasgupta P, Galustian C
ImmunoTargets and Therapy 2020, 9:115-130
Published Date: 27 July 2020
Assessing Immune Response to SARS-CoV-2 Infection
Shurin MR, Morris A, Wells A, Wheeler SE
ImmunoTargets and Therapy 2020, 9:111-114
Published Date: 11 June 2020
Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
Lorenzo-Vizcaya A, Fasano S, Isenberg DA
ImmunoTargets and Therapy 2020, 9:105-110
Published Date: 2 June 2020
Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
Tokhanbigli S, Asadirad A, Baghaei K, Piccin A, Yarian F, Parsamanesh G, Hashemi SM, Asadzadeh Aghdaei H, Zali MR
ImmunoTargets and Therapy 2020, 9:95-104
Published Date: 22 May 2020
Idiopathic CD4 Lymphocytopenia: Current Insights
Vijayakumar S, Viswanathan S, Aghoram R
ImmunoTargets and Therapy 2020, 9:79-93
Published Date: 14 May 2020
Immunotherapy for Medulloblastoma: Current Perspectives
Kabir TF, Kunos CA, Villano JL, Chauhan A
ImmunoTargets and Therapy 2020, 9:57-77
Published Date: 20 April 2020
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Elemam NM, Hannawi S, Maghazachi AA
ImmunoTargets and Therapy 2020, 9:43-56
Published Date: 9 March 2020
Novel Resolution Mediators of Severe Systemic Inflammation
Gudernatsch V, Stefańczyk SA, Mirakaj V
ImmunoTargets and Therapy 2020, 9:31-41
Published Date: 6 March 2020
Immunoinformatics and Vaccine Development: An Overview
Oli AN, Obialor WO, Ifeanyichukwu MO, Odimegwu DC, Okoyeh JN, Emechebe GO, Adejumo SA, Ibeanu GC
ImmunoTargets and Therapy 2020, 9:13-30
Published Date: 26 February 2020
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
Guallar-Garrido S, Julián E
ImmunoTargets and Therapy 2020, 9:1-11
Published Date: 13 February 2020